Top Markets
#1 ADO Protocol ADO Protocol +233.73%
#2 Islamic Coin Islamic Coin +155.42%
#3 GoPlus Security GoPlus Security +60.87%
#4 Verus Coin Verus Coin +33.01%
#5 Starpower Starpower +28.54%
#6 GAIB AID GAIB AID +24.67%
#7 Casper Network Casper Network +16.10%
#8 o1.exchange o1.exchange +13.60%
#9 Status Status +11.71%
#10 Lumia Lumia +11.38%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
TME Pharma N.V. TME Pharma N.V.

TME Pharma N.V.

ALTME
Classement en actions #32696
TME Pharma N.V., a biopharmaceutical company in the clinical development stage... TME Pharma N.V., a biopharmaceutical company in the clinical development stage based in Berlin, Germany, is dedicated to pioneering innovative therapeutic solutions for cancer. The company leverages its unique Spiegelmer platform to advance a pipeline of investigational drug candidates. Its primary oncology asset, NOX-A12, is currently being evaluated in clinical studies as a combination therapy for a range of challenging cancers, including metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. Beyond its cancer-focused efforts, TME Pharma also developed NOX-E36, which has successfully concluded Phase 1/2 clinical trials for diabetic nephropathy. The company has formed a strategic collaboration with Merck Sharp & Dohme Corp. to explore NOX-A12 in combination with Keytruda and two different chemotherapy protocols as a second-line intervention for patients battling metastatic pancreatic cancer. Founded in 1997, the organization adopted its current name, TME Pharma N.V., in July 2022, having previously operated as NOXXON Pharma N.V.
Prix de l'action
$0.10046734
Capitalisation boursière
$9.46M
Changement (1 jour)
32.34%
Changement (1 an)
-21.98%
Pays
DE
Échange TME Pharma N.V. (ALTME)

Catégorie

Healthcare
Le prix ALTME avec la capitalisation boursière de B
TME Pharma N.V. TME Pharma N.V.
ALTME
$0.10046734
Capitalisation boursière de TME Pharma N.V.(ALTME)
Capitalisation boursière: $9.46M
En August 2026, TME Pharma N.V. a une capitalisation boursière de $9.46M. Cela fait de TME Pharma N.V. la 32696th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de TME Pharma N.V. du 2016 au 2026
ALTME par rapport au top 5 des plus populaires stocks
Prix pour ALTME L’actif B La capitalisation boursière de B Résultats
TME Pharma N.V. TME Pharma N.V.
$57,880.05 $9.46M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +57,610,705.34%
TME Pharma N.V. TME Pharma N.V.
$47,668.54 $9.46M
Apple Inc. Apple Inc.
AAPL
$4.490T +47,446,700.00%
TME Pharma N.V. TME Pharma N.V.
$44,190.42 $9.46M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +43,984,756.61%
TME Pharma N.V. TME Pharma N.V.
$39,030.09 $9.46M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +38,848,430.27%
TME Pharma N.V. TME Pharma N.V.
$30,077.15 $9.46M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +29,937,138.98%